Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults

July 5, 2025 updated by: Wei XIA, PhD

The goal of this observational study is to learn about the status quo and relationship of dry eye, problematic smartphone use, bedtime procrastination, and sleep in adolescents and young adults. The main questions it aims to answer are:

  • Is there a positive correlation between problematic smartphone use and dry eye?
  • Is problematic smartphone use positively correlated with bedtime procrastination?
  • Is bedtime procrastination negatively correlated with sleep quality?
  • Is there a negative correlation between sleep quality and dry eye?
  • Is there a negative correlation between problematic smartphone use and sleep quality?
  • Is there a positive correlation between bedtime procrastination and dry eye?
  • Do bedtime procrastination and sleep quality serve as mediating factors in the relationship of problematic smartphone use and dry eye? Participants will be asked to complete several questionnaires and dry eye related examinations.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

453

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Shuping Li Master
  • Phone Number: +8618826073426
  • Email: lishpy@163.com

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510080

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

General adolescents and young adults between 14-35 years old

Description

Inclusion Criteria:

  • Adolescents and young adults aged 14 to 35 (including 14,25 years old) ;
  • Agree to participate in the studies

Exclusion Criteria:

  • Unable to communicate normally;
  • With ocular surface diseases other than dry eye and autoimmune diseases;
  • Use drugs that may cause damage to the ocular surface, such as anti glaucoma drugs, antidepressants, sex hormones, chemotherapy drugs, etc.;
  • With a history of eye trauma or eye surgery;
  • With a history of wearing contact lenses within the past month;
  • Pregnant and lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Investigation Team
  1. After informed consent, adolescents and young adults aged 14-35 years old (including 14,35 years old) are assessed by questionnaires and dry eye related examinations.
  2. The main content is Investigating the relationship among dry eye disease, problematic smartphone use, bedtime procrastination, and sleep quality.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dry eye symptoms
Time Frame: baseline
Ocular Surface Disease Index scale with 12-item will be used to measure dry eye symptoms. The scale uses Likert 5 comments, with a total score ranging from 0 to 100. And the total score reaching or exceeding 13 points indicates that participants exhibit symptoms of dry eye.
baseline
Problematic smartphone use
Time Frame: baseline
The 10-item Smartphone Addiction Scale Short Version will be used to measure the problematic smartphone use. The scale uses Likert 6 comments, with a total score ranging from 10 to 60. And higher scores indicate more severe problematic smartphone use.
baseline
sleep quality
Time Frame: baseline
The Pittsburgh Sleep Quality Index scale is used to measure participants' sleep quality. The total score ranges from 0 to 21. Higher scores indicate lower quality of sleep.
baseline
bedtime procrastination
Time Frame: baseline
There are 9 items in the Bedtime Procrastination Scale, which is used to measure participants' bedtime procrastination. The scale uses 5-point scale, with a total score ranging from 9 to 45. And higher scores indicate more severe procrastination before sleep.
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived level of stress
Time Frame: baseline
The 14-item Chinese Perceived Stress Scale will be used to measure the perceived level of stress among adolescents and young adults. The scale uses Likert 5 comments, with a total score ranging from 0 to 56. And higher scores indicate a greater pressure that individuals feel in their daily lives.
baseline
non-invasive tear film break-up time
Time Frame: baseline
Non-invasive tear film break-up time is measured by Oculus Keratograph 5M. A cut-off value of less than or equal to 10 s has been reported to be indicative of DED.
baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tear meniscus height
Time Frame: baseline
The Ocular Keratograph 5M was utilized to measure the tear meniscus height directly beneath three points: the center of the pupil, the nasal corneal limbus, and the temporal corneal limbus. The average of these three measurements was calculated to serve as the final data for tear meniscus height.
baseline
Meibomian gland loss
Time Frame: baseline
The degree of Meibomian gland loss was scored according to the meiboscore (Grade 0: no dropout, Grade 1: dropout of 2/3 of lid area, Grade 2: dropout of 1/3-2/3 of lid area, Grade 3: dropout of >2/3 of lid area).
baseline
Lipid layer thickness (LLT) and blinking pattern
Time Frame: baseline
The LLT and blinking pattern were assessed using LipiView interferometer. The LLT information included the minimum, maximum, and average for 20 seconds. The blinking pattern was obtained by determining the total blinking and partial blinking rates in 20 seconds and then calculating the partial blinking/total blinking ratio.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Wei Xia PHD, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 20, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

June 5, 2025

First Submitted That Met QC Criteria

June 5, 2025

First Posted (Actual)

June 13, 2025

Study Record Updates

Last Update Posted (Actual)

July 10, 2025

Last Update Submitted That Met QC Criteria

July 5, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dry Eye Disease (DED)

Subscribe